See more : L.G. Balakrishnan & Bros Limited (LGBBROSLTD.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Vicarious Surgical Inc. (RBOT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vicarious Surgical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- BCL Industries Limited (BCLIND.NS) Income Statement Analysis – Financial Results
- CCR S.A. (CCRO3.SA) Income Statement Analysis – Financial Results
- CyberZONE, Inc. (CYZN) Income Statement Analysis – Financial Results
- Gladstone Commercial Corporation (0IVQ.L) Income Statement Analysis – Financial Results
- Mapfre, S.A. (MPFRF) Income Statement Analysis – Financial Results
Vicarious Surgical Inc. (RBOT)
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.85M | 1.94M | 316.00K | 0.00 | 0.00 |
| Gross Profit | -1.85M | -1.94M | -316.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 47.58M | 43.90M | 22.10M | 9.80M | 7.48M |
| General & Administrative | 26.86M | 29.72M | 13.50M | 2.33M | 2.05M |
| Selling & Marketing | 6.23M | 6.46M | 2.98M | 861.00K | 250.00K |
| SG&A | 33.09M | 36.18M | 16.47M | 3.19M | 2.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Cost & Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Interest Income | 4.43M | 1.44M | 20.00K | 113.00K | 469.00 |
| Interest Expense | 25.00K | 200.00K | 89.00K | 3.00K | 0.00 |
| Depreciation & Amortization | 1.85M | 1.94M | 316.00K | 157.00K | 104.00K |
| EBITDA | -69.19M | 7.30M | -34.80M | -161.18K | -9.68M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -80.67M | -80.08M | -38.57M | -12.99M | -9.78M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 9.60M | 85.24M | 3.02M | 110.00K | 469.00K |
| Income Before Tax | -71.07M | 5.16M | -7.27M | -12.88M | -9.31M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -84.00M | -227.00K | 3.00K | -67.86K |
| Net Income | -71.07M | 89.16M | -7.04M | -12.88M | -9.31M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -14.70 | 20.77 | -2.19 | -4.91 | -1.70 |
| EPS Diluted | -14.60 | 20.99 | -2.19 | -4.91 | -1.70 |
| Weighted Avg Shares Out | 4.83M | 4.29M | 3.22M | 2.62M | 5.47M |
| Weighted Avg Shares Out (Dil) | 4.87M | 4.25M | 3.22M | 2.62M | 5.47M |
Vicarious Surgical Partners with Renowned Surgeon to Successfully Perform Two Cadaveric Ventral Hernia Procedures
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical'' or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that renowned surgeon Igor Belyansky, MD, used the Vicarious Surgical Beta 2 prototype,...
Vicarious Surgical to Participate in Upcoming Conferences
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company will be participating in the following...
Vicarious Surgical to Participate in Upcoming Conferences
WALTHAM, Mass.--( BUSINESS WIRE )--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company will be participating in...
Vicarious Surgical System Named to TIME’s List of the Best Inventions of 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the outcomes, cost, and efficiency of surgical procedures, today announced their robotic system has been named one of TIME’s...
Vicarious Surgical Inc. (RBOT) Q3 2022 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2022 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Kaitlyn Brosco - Director, Investor Relations Adam Sachs - Co Founder & CEO Bill Kelly - Chief Financial Officer Conference Call Participants...
Vicarious Surgical Reports Third Quarter 2022 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for...
Vicarious Surgical Announces Memorandum of Understanding Agreement with Pittsburgh CREATES to Advance System Design
Key Partnership Providing Further Support Toward Vicarious System Finalization, Regulatory Submission, and Commercialization Goals
Vicarious Surgical Announces Memorandum of Understanding Agreement with Pittsburgh CREATES to Advance System Design
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical'' or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it has signed a collaborative Memorandum of Understanding (“MOU”) agreement with Pittsburgh CREATES,...
Source: https://incomestatements.info
Category: Stock Reports